Table 4.
ORs and 95%CIs for pancreatic cancer related to type 2 diabetes and duration of diabetes in a San Francisco clinic-based case-control study of pancreatic cancer.
| Cases (%) | Controls (%) | OR1 (95%CI) | OR2 (95%CI) | |
|---|---|---|---|---|
| Type 2 Diabetes (>1 yr) | ||||
| No | 455 (84.9) | 780 (89.8) | 1.00 (ref) | 1.00 (ref) |
| Yes | 81 (15.1) | 89 (10.2) | 1.41 (1.02–1.96) | 1.28 (0.81–2.00) |
| Diabetes Duration | ||||
| 1 – 5 years | 39 (7.3) | 23 (2.7) | 2.75 (1.62–4.69) | 2.47 (1.25–4.85) |
| 5 – 10 years | 19 (3.5) | 25 (2.9) | 1.21 (0.65–2.23) | 0.80 (0.34–1.87) |
| >10 years | 23 (4.3) | 41 (4.7) | 0.81 (0.47–1.38) | 0.44 (0.18–1.08) |
|
| ||||
| P for trend | <0.001 | <0.001 | ||
1
Adjusted for age and sex
2
Adjusted for age, sex, race, BMI, history of pancreatitis, alcohol, smoking, family history of PC, diabetes drugs.